This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: National University of Singapore, Sengenics Sdn Bhd. Active years: 2026.
Company Filing History:
1 out of 850 
1 out of 1 Years Active: 2026
Title: Boon Cher Goh: Innovator in Cancer Research
Introduction: Boon Cher Goh is an inventor based in Singapore, known for his contributions to cancer research. He has worked with notable organizations such as Sengenics Sdn Bhd and the National University of Singapore. Although he currently holds no granted patents, his work in the field of biotechnology is significant.
Latest Patent Applications: Boon Cher Goh has filed several patent applications, including "Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression." This invention relates to nucleic acids, double-stranded nucleic acids (dsNAs), and agents for inhibiting the expression of STATS. It also includes nanoparticles comprising these nucleic acids and methods for treating cancer. Another application is titled "Methods for Determining the Likelihood of Lung Cancer." This method involves determining the level of specific biomarkers from a biological sample to assess the likelihood of lung cancer in a subject.
Conclusion: Boon Cher Goh's innovative work in cancer research highlights his commitment to advancing medical science, despite not having any granted patents at this time. His contributions to the field are noteworthy and demonstrate the potential for future advancements.